8.450USD+0.12%Mkt Cap: 54.21M USDP/E: —Last update: 2026-06-01
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap54.21M USD
Enterprise Value-93.08M USD
Revenue (TTM)53.48M USD
Gross Profit53.48M USD
Net Income (TTM)-35.04M USD
Revenue/Share9.249 USD
Last Price8.450 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-14.59
PEG—
EV/EBITDA2.28
EV/Revenue-1.74
P/S1.04
P/B1.09
EPS (TTM)-2.28
EPS (Forward)-0.58
52W Range
6.46821% of range16.10
52W High16.10 USD
52W Low6.468 USD
Profitability
Gross Margin100.00%
Oper. Margin-111.58%
EBITDA Margin-76.39%
Profit Margin-80.05%
ROE-99.33%
ROA-22.65%
Growth
Revenue Growth331.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.99M USD
CapEx (TTM)518.00K USD
FCF Margin-44.33%
FCF Yield-43.73%
Net Debt-143.69M USD
Net Debt/EBITDA3.52
Balance Sheet
Debt/Equity0.20
Current Ratio3.59
Quick Ratio3.50
Book Value/Sh7.785 USD
Cash/Share25.13 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateMar 16, 2026
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Target Range20.00 USD – 20.00 USD
# Analysts1
Ownership
Shares Out.6.58M
Float3.65M
Insiders28.49%
Institutions42.81%
Short Interest
Short Ratio2.7d
Short % Float3.24%
Short % Out.2.86%
Shares Short171.37K
Short (prev mo.)174.32K
Technical
SMA 508.265 (+2.2%)
SMA 2009.302 (-9.2%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)53.96K
Avg Vol (10d)31.37K
Technical Indicators
RSI (14)54.1
MACD0.0746
MACD Signal0.0346
MACD Hist.+0.0401
BB Upper8.844 USD
BB Middle8.172 USD
BB Lower7.501 USD
BB Width16.44%
ATR (14)0.4212 USD
Vol Ratio (20d)0.27x